PDCD1 and neoplasm: Since CD4+-TIL depletion with anti-PD-1 treatment completely lost the efficacy in Hepa1-6, our results suggest the balance between TIL-CD4+-Teff and immuno-suppressive environment inclusive of G-MDSC playing critical roles of anti-PD-1 MOAs in this tumor.